Shanghai Pharmaceuticals (02607.HK): Alipazole tablets obtained drug registration certificate in the Philippines

The Zhixun Finance APP reported that Shanghai Pharmaceuticals (02607.HK) announced that recently, the drug Alprazolam tablets produced by Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as "Shanghai Pharmaceuticals" or "the Company") subsidiary Shanghai ShangYao Chinese-Western Pharmaceutical Co., Ltd. (hereinafter referred to as "ShangYao Chinese-Western") has received a drug registration certificate issued by the Philippine Food and Drug Administration, and the drug has been approved for listing.